Old Age; Dementia Clinical Trial
Official title:
Effects of Tango on Older People With Dementia. Randomized Controlled Study.
Cognitive impairment (CI) is the leading cause of loss of autonomy and has a huge impact on physical performance and quality of life (QOL) in older people. Pharmacological treatments currently available have modest efficacy at best. Dance as both artistic and physical activity, combining emotions, social interaction, and sensory stimulation, therefore appears as a non-pharmacological intervention, which could contribute to the prevention of functional decline. Among all the existing dances, tango occupies a special place because of the cultural and emotional resonance it carries, but also because of what it leads to motor mobilization (variations in the rhythm of walking, rotation of the belts, weight transfers…). These characteristics seem to make the tango an excellent tool for the rehabilitation of balance and gait, as well as for the prevention of the loss of autonomy in older adults with CI. The objective of this study is to evaluate and compare the effectiveness of an intervention based on tango and classical physical activity.
Status | Recruiting |
Enrollment | 124 |
Est. completion date | September 29, 2023 |
Est. primary completion date | June 16, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Over 65 years old - MMSE < 21 - agreed to participate - lived permanently in the nursing home - able to walk 10 meters without human assistance Exclusion Criteria: - medical contraindications, - limited life expectancy - bedridden persons. |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier du Mont d'Or | Albigny-sur-Saône | |
France | Ehpad Du Chg Le Val D'Or | Chasselay |
Lead Sponsor | Collaborator |
---|---|
University of Burgundy |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline physical abilities (balance, gait speed and lower limbs strength) at 1 and 3 months | Physical abilities will be measured with the Short Physical Performance Battery (SPPB). This test is composed of three evaluation criteria: balance, walking speed and sit to stand [23]. Specifically, during the balance test, the subject had to maintain each of three distinct positions for 10 seconds (feet together, semi-tandem and tandem). The failure of a step was the condition to start the second test, in which the subject walked 4 meters two consecutive times. The best score was retained. Finally, the time taken to complete the fastest 5 chair lifts without the help of the upper limbs was evaluated. At the end of the three tests, a score of a maximum of 12 points could be obtained. | Before intervention/ after 1 month / after 3 months | |
Primary | Change from Baseline general physical performance at 1 and 3 months | The Timed Up & Go test (TUG) is a general physical performance test used to assess mobility, balance and locomotor performance in elderly people with balance disturbances.
The individual must stand up from a chair (which should not be leaned up against a wall), walk a distance of 3 meters, turn around, walk back to the chair and sit down - all performed at a comfortable and safe pace. One practice trial is permitted to allow the individual to familiarize him/herself with the task. Timing commences with the verbal instruction "go" and stops when the patient returns to seated position. The individual wears their regular footwear and is permitted to use their walking aid (cane/walker) with its use indicated on the data collection form. No physical assistance is given. |
Before intervention/ after 1 month / after 3 months | |
Secondary | Change from Baseline ability to perform activities of daily living (ADL) at 1 and 3 months | Ability to perform ADL will be measured using the Katz Index, consisting of a questionnaire assessing abilities in six activities of daily living (ADL): personal hygiene care, dressing, toilet use, locomotion, continence and eating. For each domain, the answer var-ies between: 1 (complete independence), 0.5 (partial independence) or 0 (absolute depend-ence). In total, an index of zero to six is obtained, where zero indicates the highest degree of dependence. | Before intervention/ after 1 month / after 3 months | |
Secondary | Change from Baseline questionnaire on Quality of Life (QoL) at 1 and 3 months | QoL will be measured with the questionnaire Quality of Life in Alzheimer disease (QoL-AD).This questionnaire is administered directly to the participant, up to a severe stage of the disease, and to the main caregiver. The participant and caregiver ratings were combined into a weighted composite score: (2 × patient score + 1 × caregiver score)/3. Thus, the answers provided by the patient remain preponderant in this model. The QoL-AD comprises 13 items (physical health, energy, mood, living situation, memory, family, marriage, friends, self, ability to carry out daily tasks, ability to do things for fun, money and life as a whole). Response options include 1(poor), 2(fair), 3(good) and 4 (excellent), for a total score of 13-52, with higher scores indicating better QoL. | Before intervention/ after 1 month / after 3 months | |
Secondary | Change from Baseline neuropsychiatric symptoms at 1 and 3 months | neuropsychiatric symptoms will be evaluated using the Neuropsychiatric Inventory-Questionnaire (NPI-Q), which is an informant-based interview that assesses neuropsychiatric symptoms of the participant. NPI consists of 10 (or 12) items that are assayed with questions, subquestions, and ratings of frequency and severity. | Before intervention/ after 1 month / after 3 months | |
Secondary | Change from Baseline signs and symptoms of major depression at 1 and 3 months | Signs and symptoms of major depression will be assessed with the Cornell Scale for Depression in Dementia (CSDD), which is a 19-item clinician-administered instrument that uses information from interviews with both the patient and a nursing staff member, a method suitable for demented patients. The scale has high interrater reliability (kw = 0.67), internal consistency (coefficient alpha: 0.84), and sensitivity. Total Cornell Scale scores correlate (0.83) with depressive subtypes of various intensity classified according to Research Diagnostic Criteria. | Before intervention/ after 1 month / after 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Completed |
NCT04537728 -
My Healthy Brain: Preserving and Promoting Brain Health Through Evidence-based Practices
|
N/A | |
Completed |
NCT06235840 -
Compensatory Brain Activity in Older Adults.
|
N/A | |
Completed |
NCT04362228 -
The Effects of Whole-body Exercise to Improve Swallowing Function in Older Adults With Dementia
|
N/A | |
Completed |
NCT04782427 -
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
|
||
Not yet recruiting |
NCT06440447 -
EXploring Patterns of Use and Effects of Adult Day Programs to Improve Trajectories of Continuing carE
|
||
Not yet recruiting |
NCT05260515 -
Protecting Alzheimer Caregivers Using Technology Through Staying Sharp
|
Phase 1/Phase 2 | |
Recruiting |
NCT05296980 -
Validation of the REMINDER Dementia Risk Reduction Program
|
N/A |